Seletracetam

Jump to: navigation, search
Seletracetam
150px
150px
Clinical data
Routes of
administration
Oral
Legal status
Legal status
  • Unscheduled (US)
Pharmacokinetic data
Bioavailability>90%
Elimination half-life8h
Identifiers
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC10H14F2N2O
Molar mass232.227
3D model (JSmol)

Seletracetam is a drug of the racetam family. It is currently being developed by UCB Pharmaceuticals as an anticonvulsant drug. While similar in structure to so-called nootropic drugs, it is not expected to have cognitive enhancing properties.

See also


Linked-in.jpg